HK18695A - Inhalation medicaments for treating respiratory disorders - Google Patents

Inhalation medicaments for treating respiratory disorders

Info

Publication number
HK18695A
HK18695A HK18695A HK18695A HK18695A HK 18695 A HK18695 A HK 18695A HK 18695 A HK18695 A HK 18695A HK 18695 A HK18695 A HK 18695A HK 18695 A HK18695 A HK 18695A
Authority
HK
Hong Kong
Prior art keywords
respiratory disorders
treating respiratory
inhalation medicaments
inhalation
medicaments
Prior art date
Application number
HK18695A
Other languages
English (en)
Inventor
James Barry Douglas Palmer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK18695(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898920392A external-priority patent/GB8920392D0/en
Priority claimed from GB898923644A external-priority patent/GB8923644D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK18695A publication Critical patent/HK18695A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
HK18695A 1989-09-08 1995-02-09 Inhalation medicaments for treating respiratory disorders HK18695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898920392A GB8920392D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923644A GB8923644D0 (en) 1989-10-20 1989-10-20 Medicaments
SG166294A SG166294G (en) 1989-09-08 1994-11-18 Inhalation medicaments for treating respiratory disorders

Publications (1)

Publication Number Publication Date
HK18695A true HK18695A (en) 1995-02-17

Family

ID=27264677

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18695A HK18695A (en) 1989-09-08 1995-02-09 Inhalation medicaments for treating respiratory disorders

Country Status (20)

Country Link
EP (1) EP0416951B1 (fr)
JP (1) JP3042867B2 (fr)
AT (1) ATE99941T1 (fr)
BE (1) BE1003053A3 (fr)
CA (1) CA2024916C (fr)
CH (1) CH680983C9 (fr)
DE (2) DE69005951T2 (fr)
DK (1) DK0416951T3 (fr)
ES (1) ES2062392T3 (fr)
FR (1) FR2651677B1 (fr)
HK (1) HK18695A (fr)
HU (1) HU211272A9 (fr)
IE (1) IE65535B1 (fr)
IL (1) IL95590A (fr)
IT (1) IT1241996B (fr)
LU (1) LU90392I2 (fr)
NL (1) NL990012I2 (fr)
NZ (1) NZ235221A (fr)
PH (1) PH27594A (fr)
SG (1) SG166294G (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
HU227519B1 (en) * 1991-12-18 2011-07-28 Astra Ab Synergic pharmaceutical composition containing combination of formoterol and budesonide
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
EP1131059B1 (fr) 1998-11-13 2003-03-05 Jago Research Ag Poudre seche pour inhalation
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
FR2798290B1 (fr) 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
PT2348032E (pt) * 2000-08-05 2015-10-14 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-'(2-furanilcarboxil)oxi]-11.beta.-hidroxi-16.alfa.- metil-3-oxo-androsta-1,4-dieno-17-carbotióico como um agente anti-inflamatório
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
JP2004526720A (ja) 2001-03-08 2004-09-02 グラクソ　グループ　リミテッド βアドレナリン受容体のアゴニスト
ES2296923T3 (es) 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CA2445839A1 (fr) 2001-04-30 2002-11-07 Glaxo Group Limited Derives anti-inflammatoires d'androstane 17.beta.-carbothioate ester avec un groupe cyclique en position 17.alpha
HU228508B1 (en) 2001-09-14 2013-03-28 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical composition containing them
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
AU2003205855A1 (en) † 2002-02-04 2003-09-02 Glaxo Group Limited Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
EP1757281A3 (fr) * 2002-02-04 2009-07-15 Glaxo Group Limited Formulation pour inhalation comprenant un glucocorticoïde et un agoniste de 2-adrénorécepteur béta
EP1483231A1 (fr) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
JP4755495B2 (ja) 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
WO2005013963A1 (fr) 2003-08-06 2005-02-17 Galephar M/F Combinaisons avantageuses pour inhalation de nacystelyn et de bronchodilatateurs
WO2005087192A2 (fr) * 2004-03-12 2005-09-22 Cipla Limited Formulations pour inhalation
CN1997418B (zh) 2004-07-16 2010-08-11 奥米罗有限公司 用于粉状药物给药的吸入器，以及用于与该吸入器一起使用的药粉筒系统
MX2009006787A (es) 2006-12-22 2009-07-10 Almirall Lab Dispositivo de inhalacion para medicamentos en forma de polvo.
CN101744792B (zh) * 2008-12-17 2013-04-17 张凯 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010138862A2 (fr) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions permettant l'administration de principes actifs par voie respiratoire et méthodes et systèmes associés
MX361286B (es) 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
WO2014177519A1 (fr) * 2013-04-29 2014-11-06 Sanofi Sa Compositions pharmaceutiques inhalables et dispositifs inhalateurs contenant ces compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2588474B1 (fr) * 1985-10-16 1987-11-27 Cird Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste

Also Published As

Publication number Publication date
JP3042867B2 (ja) 2000-05-22
DK0416951T3 (da) 1994-02-14
EP0416951A1 (fr) 1991-03-13
IT9048260A1 (it) 1992-03-07
JPH03167120A (ja) 1991-07-19
ATE99941T1 (de) 1994-01-15
DE19975040I2 (de) 2006-07-13
BE1003053A3 (fr) 1991-11-05
DE69005951T2 (de) 1994-05-26
IE65535B1 (en) 1995-11-01
DE69005951D1 (de) 1994-02-24
LU90392I2 (fr) 1999-06-28
HU211272A9 (en) 1995-11-28
ES2062392T3 (es) 1994-12-16
CA2024916C (fr) 2002-07-09
IL95590A0 (en) 1991-09-16
CH680983C1 (fr) 2008-06-25
IL95590A (en) 1996-06-18
PH27594A (en) 1993-08-31
IE903256A1 (en) 1991-03-13
CH680983C9 (fr) 2008-08-15
SG166294G (en) 1995-06-16
CH680983A5 (fr) 1992-12-31
NZ235221A (en) 1992-11-25
NL990012I2 (nl) 1999-09-01
IT1241996B (it) 1994-02-02
IT9048260A0 (it) 1990-09-07
EP0416951B1 (fr) 1994-01-12
NL990012I1 (nl) 1999-07-01
FR2651677A1 (fr) 1991-03-15
CA2024916A1 (fr) 1991-03-09
FR2651677B1 (fr) 1993-08-06

Similar Documents

Publication Publication Date Title
HK18695A (en) Inhalation medicaments for treating respiratory disorders
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
CA2123909A1 (fr) Nouvelle combinaison de formoterol et de budesonide
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
GEP20002253B (en) Pharmaceutical Aerosol Formulation, Proportioning Inhalator and Method for Treatment of Respiratory Diseases
CA2093806A1 (fr) Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline
GB9425160D0 (en) Medicaments
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
GR3015014T3 (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts.
GB9806462D0 (en) Improved compositions for inhalation
MY111155A (en) Medicaments

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070907